首页 | 本学科首页   官方微博 | 高级检索  
检索        

中国新诊断2型糖尿病胰岛素分泌和胰岛素抵抗特点调查
引用本文:安雅莉,高妍,朱倩,宁光,贾伟平,黄勤,许雯,李成江,周智广,施秉银,单忠艳,陈璐璐,许樟荣,王姮,严励,钟惠菊,姬秋和,李红,薛元明,张木勋,谷卫,郭晓蕙,高蕾丽,洪洁,刘芳,邹大进,李延兵,张小英,李桢,郭辉,赵晓娟,吴汉妮,王玉珍,赵维纲,张少玲,吴静,张南雁,杨凤英,张云,周鑫荣,任跃忠,李光伟,中国胰岛素分泌研究组.中国新诊断2型糖尿病胰岛素分泌和胰岛素抵抗特点调查[J].中华内分泌代谢杂志,2008,24(3).
作者姓名:安雅莉  高妍  朱倩  宁光  贾伟平  黄勤  许雯  李成江  周智广  施秉银  单忠艳  陈璐璐  许樟荣  王姮  严励  钟惠菊  姬秋和  李红  薛元明  张木勋  谷卫  郭晓蕙  高蕾丽  洪洁  刘芳  邹大进  李延兵  张小英  李桢  郭辉  赵晓娟  吴汉妮  王玉珍  赵维纲  张少玲  吴静  张南雁  杨凤英  张云  周鑫荣  任跃忠  李光伟  中国胰岛素分泌研究组
作者单位:1. 卫生部中日友好医院内分泌代谢中心,北京,100029
2. 北京大学第一医院内分泌科
3. 北京大学人民医院内分泌科
4. 上海交通大学医学院附属瑞金医院内分泌代谢病科
5. 上海交通大学附属上海市第六人民医院内分泌科
6. 上海,中国人民解放军第二军医大学附属长海医院内分泌科
7. 广州,中山大学附属第一医院内分泌科
8. 杭州,浙江大学附属第一医院内分泌科
9. 长沙,中南大学湘雅医学院附属第二医院内分泌科
10. 西安交通大学医学院第一附属医院内分泌科
11. 沈阳,中国医科大学附属第一医院内分泌科
12. 武汉,华中科技大学同济医学院附属协和医院内分泌科
13. 北京,中国人民解放军三0六医院内分泌科
14. 北京,中国医学科学院协和医院内分泌科
15. 广州,中山大学第二附属医院内分泌科
16. 长沙,中南大学湘雅医学院附属第一医院内分泌科
17. 西安,中国人民解放军第四军医大学西京医院内分泌科
18. 昆明医学院附属第一医院内分泌科
19. 昆明,云南省人民医院内分泌科
20. 武汉,华中科技大学同济医学院附属同济医院内分泌科
21. 杭州,浙江大学附属第二医院内分泌科
摘    要:目的 研究中国新诊断2型糖尿病患者胰岛素分泌功能(IS)及胰岛素抵抗(IR)状况.方法 对405例新诊断2型糖尿病患者和40名糖耐量正常者(对照组)测量身高、体重;行口服葡萄糖耐量试验(OGTT)及胰岛素释放试验.按空腹血糖(FPG)水平分为4组,与对照组比较.93例FPG≥8.3mmol/L者应用格列齐特(达美康)缓释片进行干预治疗1~3个月,血糖达标后重复OGTT并计算干预后的IR及IS.结果 (1)随着FPG水平的升高,糖尿病各组IR、IS逐级恶化:在FPG≥9.7mmol/L组,胰岛素敏感性为正常组的30%,IS仅为正常组的5%;(2)在FPG<9mmol/L组,IR能解释70%的血糖水平变化,而在FPG高于≥9mmol/L组,IS能解释60%的血糖变化;(3)格列齐特缓释片干预治疗IR及IS有了显著的改善.结论 新诊断2型糖尿病的IR及IS随空腹血糖升高而恶化,但是IS恶化更为严重;这种双重恶化在高血糖状态得到纠正后在相当程度上是可逆的.

关 键 词:糖尿病  2型  胰岛素抵抗  胰岛素分泌功能  干预治疗  格列齐特

Features of insulin secretion and insulin resistance in Chinese newly-diagnosed type 2 diabetes
AN Ya-li,GAO Yan,ZHU Qian,NING Guang,JIA Wei-ping,HUANG Qin,XU Wen,LI Cheng-jiang,ZHOU Zhi-guang,SHI Bing-yin,SHAN Zhong-yan,CHEN Lu-lu,XU Zhang-rong,WANG Heng,YAN Li,ZHONG Hui-ju,JI Qiu-he,LI Hong,XUE Yuan-ming,ZHANG Mu-xun,GU Wei,GUO Xiao-hui,GAO Lei-li,HONG Jie,LIU Fang,ZOU Da-jin,LI Yan-bing,ZHANG Xiao-ying,LI Zhen,GUO Hui,ZHAO Xiao-juan,WU Hart-ni,WANG Yu-zhen,ZHAO Wei-gang,ZHANG Shao-ling,WU Jing,ZHANG Nan-yan,YANG Feng-ying,ZHANG Yun,ZHOU Xin-rong,REN Yue-zhong,LI Guang-wei,China Insulin Secretion Study Group.Features of insulin secretion and insulin resistance in Chinese newly-diagnosed type 2 diabetes[J].Chinese Journal of Endocrinology and Metabolism,2008,24(3).
Authors:AN Ya-li  GAO Yan  ZHU Qian  NING Guang  JIA Wei-ping  HUANG Qin  XU Wen  LI Cheng-jiang  ZHOU Zhi-guang  SHI Bing-yin  SHAN Zhong-yan  CHEN Lu-lu  XU Zhang-rong  WANG Heng  YAN Li  ZHONG Hui-ju  JI Qiu-he  LI Hong  XUE Yuan-ming  ZHANG Mu-xun  GU Wei  GUO Xiao-hui  GAO Lei-li  HONG Jie  LIU Fang  ZOU Da-jin  LI Yan-bing  ZHANG Xiao-ying  LI Zhen  GUO Hui  ZHAO Xiao-juan  WU Hart-ni  WANG Yu-zhen  ZHAO Wei-gang  ZHANG Shao-ling  WU Jing  ZHANG Nan-yan  YANG Feng-ying  ZHANG Yun  ZHOU Xin-rong  REN Yue-zhong  LI Guang-wei  China Insulin Secretion Study Group
Abstract:Objective To investigate the features of insulin secretion(IS)and insulin resistance(IR)in Chinese newly-diagnosed type 2 diabetes. Methods Four hundred and five newly-diagnosed type 2 diabetic patients and forty normal controls were recruited. Their height and weight were measured, and levels of insulin and glucose at 0,30,60 and 120 min during oral glucose tolerance test(OGTT)were examined. The patients were stratified to four groups based on fasting plasma glucose(FPG)level. Their IR and IS were compared to controls. Patients with FPG≥8.3mmol/L were treated with gliclazide(Diamicron)for 1 to 3 months until the normalization of plasma glucose levels for more than 2 weeks. After this medication were discontinued for 48h. OGTT were then repeated to assess changes of IR and IS. Results (1) IR Was increased but IS was decreased along with the increase of FPG levels. Compared with controls, the insulin sensitivity in group with FPG≥9.7mmol/L was 30% of controls, and insulin secretion was only 5%. (2) IR could explain 70% of plasma glucose changes in the group with FPG<9mmol/L, while as in the group with FPG≥9mmol/L, it was the IS rather than IR explained 60% of plasma glucose changes. (3) The glucose levels in 23% of diabetic patients returned to non-diabetic range by the intervention treatment with gliclazide. Their insulin sensitivity and insulin secretion were significantly improved after the normalization of glucose. Conclusion Both IR and IS were worsen with the elevation of FPG in newly-diagnosed type 2 diabetes. however IS was worse than IR. Normalization of hyperglycemia with anti-diabetic agents can improve insulin secretion and ameliorate insulin sensitivity, suggesting that both the deficiencies seem to be reversible.
Keywords:Diabetes mellitus  type 2  Insulin resistance  Insulin secretion  Intervention treatment  Gliclazide
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号